Indianapolis, IN, United States of America

Prakash Bhosale

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dow Global Technolgoies LLC. Active years: 2022.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Prakash Bhosale: Innovator in Microbial Metabolic Pathways

Introduction

Prakash Bhosale is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of microbial metabolic pathways. His innovative work has led to the development of a unique patent that showcases his expertise and creativity.

Latest Patents

Prakash Bhosale holds a patent titled "Process to prepare elongated 2-ketoacids and C-5-C10 compounds therefrom via genetic modifications to microbial metabolic pathways." This patent describes genetically modified LeuCD' enzyme complexes and processes for preparing a C-C2-ketoacid utilizing these modified enzyme complexes. The microbial organisms that include these modified LeuCD enzyme complexes can be particularly useful for producing C-Caldehydes, alkanes, alcohols, and carboxylic acids, both in vivo and in vitro. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Prakash Bhosale is currently associated with Dow Global Technologies LLC, where he continues to push the boundaries of scientific research and innovation. His work at Dow has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Some of his notable coworkers include Paresh C Sanghani and Sarah Delaplane. Their collaborative efforts have played a crucial role in advancing the research and development of new biotechnological processes.

Conclusion

Prakash Bhosale is a notable inventor whose work in microbial metabolic pathways has the potential to revolutionize the production of various chemical compounds. His patent and ongoing research at Dow Global Technologies LLC highlight his commitment to innovation in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…